See analyst estimates and all valuation multiples for Pharma Diagnostics & Analytics
| Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| $11.7B | n/a | n/a | |
| $7.9B | 6.5x | 18.8x | |
| $1.3B | 6.8x | -20.7x | |
| $1.2B | 4.6x | -8.3x | |
| $891M | n/a | n/a | |
| $197M | 10.8x | 14.2x | |
| $181M | 8.3x | -5.7x | |
| $160M | n/a | n/a | |
| $40.7M | 2.3x | 12.6x | |
| $35.5M | 14.6x | -8.9x | |
| $21.3M | 18.1x | -9.0x | |
| $10.6M | n/a | n/a | |
| -$13.9M | -0.5x | n/a | |
| -$15.0M | n/a | 0.2x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Pharma Diagnostics & Analytics